This document is a quick and concise evidence-based summary to provide additional information, instruction, or guidance to complement a treatment protocol or clinical resource document.
International Germ Cell Cancer Collaborative Group (IGCCCG): International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell tumours (GCT).
For predict outcome for individual patients refer to: IGCCCG Individual 3-year progression-free survival prediction of first line metastatic non-seminoma patients.
Testicular or retroperitoneal primary tumour and No non-pulmonary visceral metastases and Post-orchiectomy markers - all of:
Any primary site and No non-pulmonary visceral metastases and Normal AFP, any ßhCG, any LDH
56% of non-seminoma 5-year PFS 90% 5-year OS 96%
Testicular or retroperitoneal primary tumour and No non-pulmonary visceral metastases and Post-orchiectomy markers - any of:
Any primary site and Non-pulmonary visceral metastases and Normal AFP, any ßhCG, any LDH
28% of non-seminoma 5-year PFS 78% 5-year OS 89%
10% of seminoma 5-year PFS 79% 5-year OS 72%r
Mediastinal primary tumour or Non-pulmonary visceral metastases or Post-orchiectomy markers -
any of:
16% of non-seminoma 5-year PFS 54% 5-year OS 67%
31/05/2017
Transferred to new eviQ website.
Previous website ID: 196
Send feedback for this page
The currency of this information is guaranteed only up until the date of printing, for any updates please check:
https://www.eviq.org.au/p/196
29 Mar 2024
Title